Please enable JavaScript to continue using this application.

Compare $DSGN vs $PRME | Chartloom

Compare

$DSGN vs $PRME

Design Therapeutics Inc · Prime Medicine Inc

DSGN

Design Therapeutics Inc

PRME

Prime Medicine Inc

Compare $DSGN vs $PRME

Comparing Design Therapeutics Inc and Prime Medicine Inc

DSGNDesign Therapeutics Inc

PRMEPrime Medicine Inc

DSGNDesign Therapeutics Inc

Market cap

$728M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

28.0%

52W performance

67.9%

FCF yield

-7.6%

PRMEPrime Medicine Inc

Market cap

$721M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

126.79x

Rev growth (TTM)

-17.9%

YTD performance

13.0%

52W performance

-38.1%

FCF yield

-21.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DSGN

PRME

Detailed metrics comparison

DSGN

Design Therapeutics Inc

PRME

Prime Medicine Inc

Market Cap

DSGN$728M

PRME$721M

Enterprise Value

DSGN$715M

PRME$673M

Price

DSGN$11.65

PRME$3.99

P/E Ratio

DSGNN/A

PRMEN/A

P/S Ratio

DSGN0.00x

PRME176.94x

EV/Sales

DSGN0.00x

PRME165.29x

EV/EBITDA

DSGN0.00x

PRME0.00x

P/B Ratio

DSGN3.83x

PRME13.58x

P/FCF Ratio

DSGNN/A

PRMEN/A

EV/FCF

DSGN-12.96x

PRME-4.29x

PEG Ratio

DSGNN/A

PRMEN/A

Forward P/E (NTM)

DSGNN/A

PRMEN/A

Forward P/S (NTM)

DSGNN/A

PRME126.79x

Revenue (TTM)

DSGN$0

PRME$4M

Revenue Growth (YoY)

DSGNN/A

PRME-17.9%

Forward Rev Growth

DSGN1360.4%

PRME22.7%

Gross Margin (TTM)

DSGN0.0%

PRME0.0%

Operating Margin (TTM)

DSGN0.0%

PRME0.0%

EBITDA Margin (TTM)

DSGN0.0%

PRME-4643.3%

Net Margin (TTM)

DSGN0.0%

PRME-4613.1%

FCF Margin (TTM)

DSGNN/A

PRME-3850.9%

Net Income (TTM)

DSGN$-71M

PRME$-188M

FCF (TTM)

DSGN$-55M

PRME$-157M

EPS (TTM)

DSGN-$1.13

PRME-$1.06

ROE (TTM)

DSGN-3403.0%

PRME-18827.0%

ROA (TTM)

DSGN-3205.0%

PRME-5911.0%

ROIC (TTM)

DSGN-3403.0%

PRME-18827.0%

Cash

DSGN$13M

PRME$47M

Debt

DSGN$0

PRME$0

Net Cash/Debt

DSGN$13M

PRME$47M

Current Ratio (TTM)

DSGN18.86x

PRME3.05x

Quick Ratio (TTM)

DSGN18.61x

PRME3.01x

Debt/Equity (TTM)

DSGN0.00x

PRME0.00x

Debt/Assets (TTM)

DSGN0.0%

PRME0.0%

Interest Coverage (TTM)

DSGNN/A

PRMEN/A

Net Debt/EBITDA (TTM)

DSGN0.00x

PRME0.00x

Beta

DSGN1.72

PRME2.35

52W Performance

DSGN67.9%

PRME-38.1%

YTD Performance

DSGN28.0%

PRME13.0%

% from 52W High

DSGN-32.5%

PRME-40.0%

% from 52W Low

DSGN120.6%

PRME49.4%

Asset Turnover (TTM)

DSGN0.00x

PRME0.01x

FCF Yield (TTM)

DSGN-7.6%

PRME-21.8%

Earnings Yield (TTM)

DSGN-9.7%

PRME-26.1%

Dividend Yield (TTM)

DSGNN/A

PRMEN/A

Rule of 40

DSGN0.0

PRME-3,868.8

EV/GP/RG

DSGNN/A

PRMEN/A

Ticker research

View DSGN research View PRME research

Metric	DSGN Design Therapeutics Inc	PRME Prime Medicine Inc
Market & Valuation
Market Cap	$728M	$721M
Enterprise Value	$715M	$673M
Price	$11.65	$3.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	176.94x
EV/Sales	0.00x	165.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.83x	13.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.96x	-4.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	126.79x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	-17.9%
Forward Rev Growth	1360.4%	22.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4643.3%
Net Margin (TTM)	0.0%	-4613.1%
FCF Margin (TTM)	N/A	-3850.9%
Net Income (TTM)	$-71M	$-188M
FCF (TTM)	$-55M	$-157M
EPS (TTM)	-$1.13	-$1.06
ROE (TTM)	-3403.0%	-18827.0%
ROA (TTM)	-3205.0%	-5911.0%
ROIC (TTM)	-3403.0%	-18827.0%
Financial Health
Cash	$13M	$47M
Debt	$0	$0
Net Cash/Debt	$13M	$47M
Current Ratio (TTM)	18.86x	3.05x
Quick Ratio (TTM)	18.61x	3.01x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.72	2.35
52W Performance	67.9%	-38.1%
YTD Performance	28.0%	13.0%
% from 52W High	-32.5%	-40.0%
% from 52W Low	120.6%	49.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-7.6%	-21.8%
Earnings Yield (TTM)	-9.7%	-26.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,868.8
EV/GP/RG	N/A	N/A
Ticker research	View DSGN research	View PRME research

Valuation

P/S Ratio

DSGN

0.00x

PRME

176.94x

EV/FCF

DSGN

-12.96x

PRME

-4.29x

Growth & revenue

Revenue Growth TTM

PRME

-17.9%

Forward Revenue Growth

DSGN

1360.4%

PRME

22.7%

Profitability & performance

Gross Margin

DSGN

0.0%

PRME

0.0%

ROE

DSGN

-3403.0%

PRME

-18827.0%

FCF Yield %

DSGN

-7.6%

PRME

-21.8%

52-Week Performance

DSGN

67.9%

PRME

-38.1%

Detailed metrics comparison

DSGN

Design Therapeutics Inc

PRME

Prime Medicine Inc

Market Cap

DSGN$728M

PRME$721M

Enterprise Value

DSGN$715M

PRME$673M

Price

DSGN$11.65

PRME$3.99

P/E Ratio

DSGNN/A

PRMEN/A

P/S Ratio

DSGN0.00x

PRME176.94x

EV/Sales

DSGN0.00x

PRME165.29x

EV/EBITDA

DSGN0.00x

PRME0.00x

P/B Ratio

DSGN3.83x

PRME13.58x

P/FCF Ratio

DSGNN/A

PRMEN/A

EV/FCF

DSGN-12.96x

PRME-4.29x

PEG Ratio

DSGNN/A

PRMEN/A

Forward P/E (NTM)

DSGNN/A

PRMEN/A

Forward P/S (NTM)

DSGNN/A

PRME126.79x

Revenue (TTM)

DSGN$0

PRME$4M

Revenue Growth (YoY)

DSGNN/A

PRME-17.9%

Forward Rev Growth

DSGN1360.4%

PRME22.7%

Gross Margin (TTM)

DSGN0.0%

PRME0.0%

Operating Margin (TTM)

DSGN0.0%

PRME0.0%

EBITDA Margin (TTM)

DSGN0.0%

PRME-4643.3%

Net Margin (TTM)

DSGN0.0%

PRME-4613.1%

FCF Margin (TTM)

DSGNN/A

PRME-3850.9%

Net Income (TTM)

DSGN$-71M

PRME$-188M

FCF (TTM)

DSGN$-55M

PRME$-157M

EPS (TTM)

DSGN-$1.13

PRME-$1.06

ROE (TTM)

DSGN-3403.0%

PRME-18827.0%

ROA (TTM)

DSGN-3205.0%

PRME-5911.0%

ROIC (TTM)

DSGN-3403.0%

PRME-18827.0%

Cash

DSGN$13M

PRME$47M

Debt

DSGN$0

PRME$0

Net Cash/Debt

DSGN$13M

PRME$47M

Current Ratio (TTM)

DSGN18.86x

PRME3.05x

Quick Ratio (TTM)

DSGN18.61x

PRME3.01x

Debt/Equity (TTM)

DSGN0.00x

PRME0.00x

Debt/Assets (TTM)

DSGN0.0%

PRME0.0%

Interest Coverage (TTM)

DSGNN/A

PRMEN/A

Net Debt/EBITDA (TTM)

DSGN0.00x

PRME0.00x

Beta

DSGN1.72

PRME2.35

52W Performance

DSGN67.9%

PRME-38.1%

YTD Performance

DSGN28.0%

PRME13.0%

% from 52W High

DSGN-32.5%

PRME-40.0%

% from 52W Low

DSGN120.6%

PRME49.4%

Asset Turnover (TTM)

DSGN0.00x

PRME0.01x

FCF Yield (TTM)

DSGN-7.6%

PRME-21.8%

Earnings Yield (TTM)

DSGN-9.7%

PRME-26.1%

Dividend Yield (TTM)

DSGNN/A

PRMEN/A

Rule of 40

DSGN0.0

PRME-3,868.8

EV/GP/RG

DSGNN/A

PRMEN/A

Ticker research

View DSGN research View PRME research

Metric	DSGN Design Therapeutics Inc	PRME Prime Medicine Inc
Market & Valuation
Market Cap	$728M	$721M
Enterprise Value	$715M	$673M
Price	$11.65	$3.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	176.94x
EV/Sales	0.00x	165.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.83x	13.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.96x	-4.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	126.79x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	-17.9%
Forward Rev Growth	1360.4%	22.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4643.3%
Net Margin (TTM)	0.0%	-4613.1%
FCF Margin (TTM)	N/A	-3850.9%
Net Income (TTM)	$-71M	$-188M
FCF (TTM)	$-55M	$-157M
EPS (TTM)	-$1.13	-$1.06
ROE (TTM)	-3403.0%	-18827.0%
ROA (TTM)	-3205.0%	-5911.0%
ROIC (TTM)	-3403.0%	-18827.0%
Financial Health
Cash	$13M	$47M
Debt	$0	$0
Net Cash/Debt	$13M	$47M
Current Ratio (TTM)	18.86x	3.05x
Quick Ratio (TTM)	18.61x	3.01x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.72	2.35
52W Performance	67.9%	-38.1%
YTD Performance	28.0%	13.0%
% from 52W High	-32.5%	-40.0%
% from 52W Low	120.6%	49.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-7.6%	-21.8%
Earnings Yield (TTM)	-9.7%	-26.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,868.8
EV/GP/RG	N/A	N/A
Ticker research	View DSGN research	View PRME research